The report covers forecast and analysis for the stroke diagnostics and therapeutics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the stroke diagnostics and therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the stroke diagnostics and therapeutics market on a global level.

This report offers comprehensive coverage on global stroke diagnostics and therapeutics market along with, market trends, drivers, and restraints of stroke diagnostics and therapeutics market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the stroke diagnostics and therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the stroke diagnostics and therapeutics market by segmenting the market based on diagnostics, therapeutics, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The diagnostics market covered under this study includes magnetic resonance imaging, computed tomography scan, electrocardiography, and carotid ultrasound. The therapeutics segmentation includes tissue plasminogen activator, antiplatelet, antihypertensive and anticoagulant. The application segmentation includes haemorrhagic stroke and ischemic stroke. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into the U.S., U.K., Germany, France, Japan, China, India, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck  Co., Inc

This report segments the global stroke diagnostics and therapeutics market as follows:

Global Stroke Diagnostics and Therapeutics Market:  Diagnostics Analysis

• Magnetic Resonance Imaging (MRI)


• Computed Tomography Scan (CT scan)


• Electrocardiography


• Carotid Ultrasound


• Cerebral Angiography


• Others

Global Stroke Diagnostics and Therapeutics Market: Therapeutics Analysis

• Tissue Plasminogen Activator


• Antiplatelet


• Antihypertensive


• Anticoagulant

Global Stroke Diagnostics and Therapeutics Market: Application Analysis

• Haemorrhagic Stroke


• Ischemic Stroke

Global Stroke Diagnostics and Therapeutics Market: Regional Segment Analysis

• North America
  
  
  
  • U.S.
  
  
  
  


• Europe
  
  
  
  • U.K.
  
  
  • Germany
  
  
  • France
  
  
  
  


• Asia Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  
  


• Latin America
  
  
  
  • Brazil
  
  
  
  


• Middle East And Africa